Abstract
UK-38,006, 6 beta-iodopenicillanic acid, was shown to be a potent inhibitor of beta-lactamase enzymes. It potentiated the antibacterial action of ampicillin in vitro against beta-lactamase-producing strains of Staphylococcus aureus, Haemophilus influenzae, Bacteroides fragilis. Neisseria gonorrhoeae, and many Enterobacteriaceae. This ability to synergize with ampicillin was also demonstrated in vivo after oral administration of UK-38,006 to experimentally infected mice. UK-38,006 was also shown to synergize in vitro with other penicillins and cephalosporins against beta-lactamase-producing strains of Escherichia coli, Proteus mirabilis, and Klebsiella species.
Publisher
American Society for Microbiology
Subject
Infectious Diseases,Pharmacology (medical),Pharmacology
Reference15 articles.
1. Bacampicillin, a new orally well-absorbed derivative of ampiciin;Bodin N. O.;Antimicrob. Agents Chemother.,1975
2. Inhibition of Escherichia coli TEM-2.lactamase by the sulphated compounds izmenolide, p lin and sodium dodecyl suphate;Bush K.;J. Antibiot.,1980
3. A semisynthetic penicllinae inactivator;Cartwright S. J.;Nature (London),1979
4. Structure elucidation of MM 17880, a new fused fJ-lactam antibiotic isolated from Streptomyces olivaceuse: a mild fi-lactam degradation reaction;Corbett D. F.;J. Chem. Soc. Chem. Commun. p.,1977
5. CP-45,899, a$,-lactamase.inhibitor that extends the antibacterial spectrum of f,-lactams: initial bacteriological characterization;English A. R.;Antimicrob. Agents Chemother.,1978
Cited by
17 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献